Vaccine via the nasal passage could be the new line of defence against Strep A
As Streptococcus A cases continue to be prevalent in Queensland and internationally, a new nasal vaccine could provide long-term protection from the deadly bacteria.
Potential vaccine to prevent deadly Strep A infection
Griffith University Institute for Glycomics researchers are closer to the development of a new vaccine aimed at preventing the deadly Streptococcus A (Strep A), which kills more than 500,000 people globally per year.
